CLINICAL PREDICTORS AND NATURAL-HISTORY OF ATRIAL-FIBRILLATION IN PATIENTS WITH DDD PACEMAKERS

被引:23
作者
GROSS, J
MOSER, S
BENEDEK, ZM
ANDREWS, C
FURMAN, S
机构
[1] MONTEFIORE MED CTR,DEPT CARDIOTHORAC SURG,BRONX,NY 10467
[2] MONTEFIORE MED CTR,DEPT MED,BRONX,NY 10467
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 1990年 / 13卷 / 12期
关键词
ATRIAL FIBRILLATION; DDD PACEMAKERS;
D O I
10.1111/j.1540-8159.1990.tb06898.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Effective DDD pacing requires that patients remain free of atrial fibrillation (AF). Four hundred eighty-nine consecutive patients undergoing initial transvenous DDD implants were reviewed to determine the incidence of postimplant AF in this population and to assess what factors, known at implant, predicted the later development of AF. The variables analyzed included age, sex, indication for implant (dominant SA or AV node disease), history of AF, atrial electrogram characteristics and pacing threshold, and the status of retrograde conduction. Forty-eight patients (9.8%) developed AF a mean of 23 months postimplant, and 11 of these patients returned to sinus rhythm and were managed once again in DDD for significant periods. A prior history of AF and the presence of dominant sinoatrial disease were far more prevalent in the patients who developed AF (P < 0.001) though the vast majority of patients with these two independent risk factors remained in sinus rhythm through much or all of their follow-up period. We conclude that the incidence of AF is not of a magnitude to preclude DDD pacing in the vast majority of patients in sinus rhythm at implant.
引用
收藏
页码:1828 / 1831
页数:4
相关论文
共 9 条
[1]  
BELOTT PH, 1985, MODERN CARDIAC PACIN, P439
[2]   DDD PACEMAKERS MAXIMIZE HEMODYNAMIC BENEFITS AND MINIMIZE COMPLICATIONS FOR MOST PATIENTS [J].
BYRD, CL ;
SCHWARTZ, SJ ;
GONZALES, M ;
BYRD, CB ;
CIRALDO, RJ ;
SIVINA, M ;
YAHR, WZ ;
GREENBERG, JJ .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1988, 11 (11) :1911-1916
[3]  
FEVER JM, 1989, AM J CARDIOL, V64, P1376
[4]   ATRIOVENTRICULAR AND VENTRICULO-ATRIAL CONDUCTION TIMES IN PATIENTS UNDERGOING PACEMAKER IMPLANT [J].
HAYES, DL ;
FURMAN, S .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1983, 6 (01) :38-46
[5]   HEMODYNAMIC-EFFECTS OF ATRIAL SYNCHRONIZATION IN ACUTE AND LONG-TERM VENTRICULAR PACING [J].
KAPPENBERGER, L ;
GLOOR, HO ;
BABOTAI, I ;
STEINBRUNN, W ;
TURINA, M .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1982, 5 (05) :639-645
[6]  
Karlof I, 1974, Acta Med Scand Suppl, V565, P1
[7]   PHYSIOLOGICAL VERSUS SINGLE-RATE VENTRICULAR PACING - A DOUBLE-BLIND CROSSOVER STUDY [J].
KRISTENSSON, BE ;
ARNMAN, K ;
SMEDGARD, P ;
RYDEN, L .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1985, 8 (01) :73-84
[8]   A COMPARISON OF THE ACUTE AND LONG-TERM HEMODYNAMIC-EFFECTS OF VENTRICULAR INHIBITED AND ATRIAL SYNCHRONOUS VENTRICULAR INHIBITED PACING [J].
KRUSE, I ;
ARNMAN, K ;
CONRADSON, TB ;
RYDEN, L .
CIRCULATION, 1982, 65 (05) :846-855
[9]   INTERMITTENT PACEMAKER SYNDROME - REVISION OF VVI PACEMAKER TO A NEW CARDIAC PACING MODE FOR TACHY-BRADY SYNDROME [J].
MCCORMICK, DJ ;
SHUCK, JW ;
ANSINELLI, RA .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1987, 10 (02) :372-377